Feedback / Questions
EO-1022 - Concentra Biosciences
EO-3021 - Concentra Biosciences
https://www.prnewswire.com/news-releases/elevation-oncology-to-discontinue-development-of-eo-3021-advancing-eo-1022-while-evaluating-strategic-options-302406229.html
Mar 20, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next